Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2018-18388
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
eScan Agent Application (MWAGENT.EXE) 4.0.2.98 in MicroWorld Technologies eScan 14.0 allows remote or local attackers to execute arbitrary commands by sending a carefully crafted payload to TCP port 2222.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
MicroWorld Technologies eScan eScan Agent Application 访问控制错误漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
MicroWorld Technologies eScan是美国MicroWorld公司的一套杀毒软件。该软件能够有效防止间谍软件、恶意软件和垃圾邮件等。eScan Agent Application(MWAGENT.EXE)是其中的一个代理端应用程序。 MicroWorld Technologies eScan 14.0版本中的eScan Agent Application (MWAGENT.EXE) 4.0.2.98版本存在访问控制错误漏洞。攻击者可通过向2222 TCP端口发送特制的负载利用该漏洞执
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2018-18388
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2018-18388
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2018-18388

No comments yet


Leave a comment